What is the webinar about?
Under MDR, Article 117 has significantly increased the regulatory requirements. In many cases, this now requires the involvement of an MDR-designated Notified Body, providing a formal Notified Body Opinion (NBOp).
If you manufacture combination products, this webinar will help you:
- to understand how these changes are affecting you;
- prepare documentation;
- and submit your products for review.
What will participants gain?
- Understand what Article 117 means for your next submission
- Learn which documents Notified Bodies expect (and why)
- Learn how to reduce rework and regulatory queries
- See how the NBOp process works in practice
- Participate in a live Q&A
Speakers

Theresa
Jeary
Global Head — Medicinal & Biologics, BSI





